1248
V. N. Yarovenko et al.
SHORT PAPER
Table 2 Spectroscopic Data for 3a–d and 5b–e
Product 1H NMR (300.13 MHz, DMSO-d6) d, J (Hz)
13C NMR (75.47 MHz, DMSO-d6) d
MS m/z [M+]
3a
3b
3c
3d
4.2 (s, 2 H, SCH2), 7.2 (t, J = 7.6, 1 Harom para to 37.387 (CH2), 121.092 (CHarom ortho to N), 125.037 (CHarom
312
N), 7.4 (t, J = 7.6, 2 Harom ortho to N), 7.9 (d,
J = 7.6, 2 Harom meta to N), 10.7 (s, 1 H, NH)
para to N), 129.023 (CHarom meta to N), 137.775 (Carom),
169.015 (C=O), 193.623 (C=S)
4.3 (s, 2 H, SCH2), 7.5 (d, J = 8.7, 2 Harom ortho to 37.458 (CH2), 122.654 (CHarom ortho to N), 128.935 (CHarom
N), 7.9 (d, J = 8.7, 2 Harom meta to N), 10.1 (s, 1 H, meta to N, para to N), 136.806 (Carom), 169.015 (C=O), 193.623
NH) (C=S)
346
4.25 (s, 2 H, SCH2), 7.0 (d, J = 8.9, 2 Harom ortho 33.756 (CH2), 53.687 (OCH3), 116.963 (CHarom para to N),
to N), 7.65 (d, J = 8.9, 2 Harom meta to N), 10.1 (s, 123.036 (CHarom ortho to N), 131.852 (CHarom meta to N),
341
1 H, NH)
137.21 (Carom), 167.065 (C=O), 191.025 (C=S)
1.25 (t, J = 7.44, 3 H, CH3), 1.35 (t, J = 7.11, 3 H, 14.201 (CH3), 15.208 (CH3), 22.042 (CH2), 37.715 (CH2 rhod), 418
CH3), 2.7 (q, J = 4.77, 2 H, CH2), 4.15 (s, 2 H,
SCH2), 4.35 (q, J = 4.08, 2 H, OCH2), 7.0 (s, 1
Harom), 11.8 (s, 1 H, NH)
60.524 (OCH2), 114.101 (Cthioph), 119.935 (CHthioph), 137.435
(Cthioph), 143.771 (Cthioph), 156.037 (C=O), 163.490 (C=O),
164.267 (C=S), 189.335 (C=S)
5b
5c
5d
5e
3.7 (d, J = 7.44, 2 H, CH2), 4.2 (s, 2 H, SCH2), 5.2 38.248 (CH2 rhod), 47.126 (CH2N), 113.587 (CH2=CH),
(m, 2 H, =CH2), 5.9 (m, 1 H, =CH) 139.356 (CH2=CH), 168.973 (C=O), 191.345 (C=S)
173
174
212
200
1.2 (m, 4 H, CH2CH2), 1.7 (m, 1 H, NCH), 4.0 (s, 12.478 (CH2, cyclopropyl), 25.417 (CH, cyclopropyl), 38.410
2 H, SCH2) (CH2, rhod), 165.073 (C=O), 195.793 (C=S).
4.25 (s, 2 H, SCH2), 6.5 (d, J = 4.81, 1 Harom), 6.6 39.214 (CH2), 110.207 (CHarom meta to N), 157.959 (CHarom
(t, J = 4.77, 1 Harom), 8.2 (d, J = 4.8, 1 Harom
)
ortho to N), 163.353 (C=S), 168.127 (C=O)
4.25 (s, 2 H, SCH2), 7.5 (s, 1 H, N=CH)
39.487 (CH2), 145.344 (N=CH), 156.269 (C=O), 168.655
(C=S)
stirred at r.t. for 1.5 h. Then oxamic acid thiohydrazide 2a–d (0.5
mmol) or the amine 4a–e (0.5 mmol) was added, and the mixture
was refluxed for 4 h. A 2 M HCl solution (30 mL) was added, and
the mixture was extracted with EtOAc (4 × 15 mL). The combined
organic phases were dried (MgSO4) and concentrated. The residue
was recrystallized from MeCN (Tables 1 and 2).
(4) Krayushkin, M. M.; Yarovenko, V. N.; Zavarzin, I. V. Russ.
Chem. Bull. 2004, 53, 517; Chem. Abstr. 2005, 142, 155844.
(5) Yarovenko, V. N.; Shirokov, A. V.; Krupinova, O. N.;
Zavarzin, I. V.; Krayushkin, M. M. Zh. Org. Khim. 2003, 39,
1204; Chem. Abstr. 2004, 141, 54236.
(6) Strube, R. E. US Patent 2781347, 1957; Chem. Abstr. 1957,
51, 11390g.
(7) Johannes, S. B.; Klifford, S. L. J. Am. Chem. Soc. 1931, 53,
2688.
References
(8) Wan, T. S.; Cheng, L. L.; Su, L. Y.; Siew, P. L.; Min, M. S.
Bioorg. Med. Chem. Lett. 2001, 11, 91.
(9) Kline, S. German Patent DE 2325038, 1973; Chem. Abstr.
1974, 80, 82945a.
(10) Strube, R. E. Org. Synth. Coll. Vol. IV; Wiley: New York,
1963, 967.
(1) Lesyk, R.; Zimenkovsky, B. Curr. Org. Chem. 2004, 8,
1547.
(2) Turkevych, N.; Stebluk, P.; Vladimirska, O.; Zdorenko, V.
Sb. Nauchn. Rab., L’vov. Gos. Med. Inst. 1963, 24, 22;
Chem. Abstr. 1965, 62: 9120d.
(3) Aziz, S. I. Egypt. J. Chem. 2001, 44, 269; Chem. Abstr.
2002, 137, 78909.
Synthesis 2006, No. 8, 1246–1248 © Thieme Stuttgart · New York